Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 10/2009

01-10-2009 | Brief Report

Outbreak of multiresistant Acinetobacter baumannii in a polyvalent intensive care unit: clinical, epidemiological analysis and PFGE-printing evolution

Authors: J. Monterrubio-Villar, C. González-Velasco, S. Valdezate-Ramos, A. Córdoba-López, P. Villalón-Panzano, J. A. Saéz-Nieto

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 10/2009

Login to get access

Abstract

An outbreak of multidrug-resistant Acinetobacter baumannii (MRAB) occurred over the course of a 27-week period in our adult polyvalent intensive care unit (ICU). Twenty-one patients were affected, and 72 strains were identified from different clinical samples. The strains were resistant to all antibiotics except for colistin and ampicillin/sulbactam. Forty-nine MRAB strains collected from 18 patients were analysed by pulsed-field gel electrophoresis (PFGE). This analysis revealed four highly-related PFGE types (genetic similarity index >90%) termed 1, 2, 3 and 4, that were isolated in 13, seven, one, and three patients, respectively. A single PFGE type was identified from five of ten patients with successive isolation of MRAB; in the other five patients, two or three PFGE types were detected. This suggested phased evolution of PFGE types 2, 3 and 4 from PFGE type 1. Global mortality was high (13 patients; 62%). Non-survivors had higher APACHE II scores than survivors on the date that MRAB was isolated (OR = 1.57; 95% CI [1.02, 2.44]). The outbreak was controlled after implementation of an extensive infection control program.
Literature
1.
go back to reference Villegas MV, Hartstein AI (2003) Acinetobacter outbreaks, 1977–2000. Infect Control Hosp Epidemiol 24:284–295PubMedCrossRef Villegas MV, Hartstein AI (2003) Acinetobacter outbreaks, 1977–2000. Infect Control Hosp Epidemiol 24:284–295PubMedCrossRef
2.
go back to reference Wendt C, Dietze B, Dietz E, Rüden H (1997) Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol 35:1394–1397PubMed Wendt C, Dietze B, Dietz E, Rüden H (1997) Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol 35:1394–1397PubMed
3.
go back to reference Riley TV, Webb SA, Cadwallader H, Briggs BD, Christiansen L, Bowman RA (1996) Outbreak of gentamicin-resistant Acinetobacter baumannii in an intensive care unit: clinical, epidemiological and microbiological features. Pathology 28:359–363PubMedCrossRef Riley TV, Webb SA, Cadwallader H, Briggs BD, Christiansen L, Bowman RA (1996) Outbreak of gentamicin-resistant Acinetobacter baumannii in an intensive care unit: clinical, epidemiological and microbiological features. Pathology 28:359–363PubMedCrossRef
4.
go back to reference Corbella X, Montero A, Pujol M, Dominguez MA, Ayats J, Argerich MJ, Garrigosa F, Ariza J, Gudiol F (2000) Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol 38:4086–4095PubMed Corbella X, Montero A, Pujol M, Dominguez MA, Ayats J, Argerich MJ, Garrigosa F, Ariza J, Gudiol F (2000) Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol 38:4086–4095PubMed
5.
go back to reference Garcia-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, Jiménez-Jiménez FJ, Pérez-Paredes C, Barrero-Almodóvar AE, Gili-Miner M (2001) Risk factors for Acinetobacter baumannii bacteremia in critically ill patients: a cohort study. Clin Infect Dis 33:939–946PubMedCrossRef Garcia-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, Jiménez-Jiménez FJ, Pérez-Paredes C, Barrero-Almodóvar AE, Gili-Miner M (2001) Risk factors for Acinetobacter baumannii bacteremia in critically ill patients: a cohort study. Clin Infect Dis 33:939–946PubMedCrossRef
6.
go back to reference Bou G, Cerveró G, Dominguez MA, Quereda C, Martínez-Beltrán J (2000) Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not solely to the presence of beta-lactamases. J Clin Microbiol 38:3299–3305PubMed Bou G, Cerveró G, Dominguez MA, Quereda C, Martínez-Beltrán J (2000) Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not solely to the presence of beta-lactamases. J Clin Microbiol 38:3299–3305PubMed
7.
go back to reference del Mar Tomas M, Cartelle M, Pertega S, Beceiro A, Llinares P, Canle D, Molina F, Villanueva R, Cisneros JM, Bou G (2005) Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection. Clin Microbiol Infect 11:540–546PubMedCrossRef del Mar Tomas M, Cartelle M, Pertega S, Beceiro A, Llinares P, Canle D, Molina F, Villanueva R, Cisneros JM, Bou G (2005) Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection. Clin Microbiol Infect 11:540–546PubMedCrossRef
8.
go back to reference Schreckenberger PC, von Graevenitz A (1999) Acinetobacter, Alcaligenes, Moraxella, Methylobacterium, and other nonfermentative gram-negative rods. In: Murray PR (ed) Manual of clinical microbiology, 7th edn. ASM Press, Washington DC, pp 539–560 Schreckenberger PC, von Graevenitz A (1999) Acinetobacter, Alcaligenes, Moraxella, Methylobacterium, and other nonfermentative gram-negative rods. In: Murray PR (ed) Manual of clinical microbiology, 7th edn. ASM Press, Washington DC, pp 539–560
9.
go back to reference Clinical and Laboratory Standards Institute (2008) Performance standards for antimicrobial susceptibility testing. 18th supplement, M100-S18. CLSI, Wayne, PA, USA Clinical and Laboratory Standards Institute (2008) Performance standards for antimicrobial susceptibility testing. 18th supplement, M100-S18. CLSI, Wayne, PA, USA
10.
go back to reference Seifert H, Dolzani L, Bressan R, van der Reijden T, van Strijen B, Stefanik D, Heersma H, Dijkshoorn L (2005) Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol 43:4328–4335PubMedCrossRef Seifert H, Dolzani L, Bressan R, van der Reijden T, van Strijen B, Stefanik D, Heersma H, Dijkshoorn L (2005) Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol 43:4328–4335PubMedCrossRef
11.
go back to reference Nei M, Li WH (1979) Mathematical model for studying genetic variation in terms of restriction endonucleases. Proc Natl Acad Sci USA 76:5269–5273PubMedCrossRef Nei M, Li WH (1979) Mathematical model for studying genetic variation in terms of restriction endonucleases. Proc Natl Acad Sci USA 76:5269–5273PubMedCrossRef
12.
go back to reference Garner JS (1996) Guideline for isolation precautions in hospitals. The hospital infection control practices advisory committee. Infect Control Hosp Epidemiol 17:53–80PubMedCrossRef Garner JS (1996) Guideline for isolation precautions in hospitals. The hospital infection control practices advisory committee. Infect Control Hosp Epidemiol 17:53–80PubMedCrossRef
13.
go back to reference Das I, Lambert P, Hill D, Noy M, Bion J, Elliott T (2002) Carbapenem-resistant Acinetobacter and role of curtains in an outbreak in intensive care units. J Hosp Infect 50:110–114PubMedCrossRef Das I, Lambert P, Hill D, Noy M, Bion J, Elliott T (2002) Carbapenem-resistant Acinetobacter and role of curtains in an outbreak in intensive care units. J Hosp Infect 50:110–114PubMedCrossRef
14.
go back to reference Denton M, Wilcox MH, Parnell P, Green D, Keer V, Hawkey PM, Evans I, Murphy P (2004) Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit. J Hosp Infect 56:106–110PubMedCrossRef Denton M, Wilcox MH, Parnell P, Green D, Keer V, Hawkey PM, Evans I, Murphy P (2004) Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit. J Hosp Infect 56:106–110PubMedCrossRef
15.
go back to reference Katragkou A, Kotsiou M, Antachapoulos C, Benos A, Sofianou D, Tamiolaki M, Roilides E (2006) Acquisition of imipenem-resistant Acinetobacter baumannii in a pediatric intensive care unit: a case-control study. Intensive Care Med 32:1384–1391PubMedCrossRef Katragkou A, Kotsiou M, Antachapoulos C, Benos A, Sofianou D, Tamiolaki M, Roilides E (2006) Acquisition of imipenem-resistant Acinetobacter baumannii in a pediatric intensive care unit: a case-control study. Intensive Care Med 32:1384–1391PubMedCrossRef
16.
go back to reference Weernink A, Severin WP, Tjernberg I, Dijkshoorn L (1995) Pillows, an unexpected source of Acinetobacter. J Hosp Infect 29:189–199PubMedCrossRef Weernink A, Severin WP, Tjernberg I, Dijkshoorn L (1995) Pillows, an unexpected source of Acinetobacter. J Hosp Infect 29:189–199PubMedCrossRef
17.
go back to reference Garnacho-Montero J, Ortiz-Leyba C, Fernández-Hinojosa E, Aldabó-Pallás T, Cayuela A, Marquez-Vácaro JA, Garcia-Curiel A, Jiménez-Jiménez FJ (2005) Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings. Intensive Care Med 31:649–655PubMedCrossRef Garnacho-Montero J, Ortiz-Leyba C, Fernández-Hinojosa E, Aldabó-Pallás T, Cayuela A, Marquez-Vácaro JA, Garcia-Curiel A, Jiménez-Jiménez FJ (2005) Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings. Intensive Care Med 31:649–655PubMedCrossRef
18.
go back to reference Alvarez-Lerma F, Palomar M, Insausti J, Olaechea P, Cerdá E, Castillo F, Martínez-Pellús A (2005) Infections caused by Acinetobacter spp. in critically ill ICU patients. Enferm Infecc Microbiol Clin 23:533–539PubMedCrossRef Alvarez-Lerma F, Palomar M, Insausti J, Olaechea P, Cerdá E, Castillo F, Martínez-Pellús A (2005) Infections caused by Acinetobacter spp. in critically ill ICU patients. Enferm Infecc Microbiol Clin 23:533–539PubMedCrossRef
19.
go back to reference Cefai C, Richards J, Gould FK, McPeake P (1990) An outbreak of Acinetobacter respiratory tract infection resulting from incomplete disinfection of ventilatory equipment. J Hosp Infect 15:177–182PubMedCrossRef Cefai C, Richards J, Gould FK, McPeake P (1990) An outbreak of Acinetobacter respiratory tract infection resulting from incomplete disinfection of ventilatory equipment. J Hosp Infect 15:177–182PubMedCrossRef
Metadata
Title
Outbreak of multiresistant Acinetobacter baumannii in a polyvalent intensive care unit: clinical, epidemiological analysis and PFGE-printing evolution
Authors
J. Monterrubio-Villar
C. González-Velasco
S. Valdezate-Ramos
A. Córdoba-López
P. Villalón-Panzano
J. A. Saéz-Nieto
Publication date
01-10-2009
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2009
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-009-0777-6

Other articles of this Issue 10/2009

European Journal of Clinical Microbiology & Infectious Diseases 10/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine